M-A | Heparin full-dose anticoagulation is beneficial for non-critically ill COVID-19 patients
SPECIALTIES,
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysi…
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysi…
In this blog post I will summarize a 2022 Cochrane systematic review titled Anticoagulants for people hospitalised with COVID-19.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients…
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis…
Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic…
The latest evidence and resources for midwives and clinical support staff, and a chance to help us improve these blogs. The…
The latest evidence and resources for allied health professionals and clinical support staff, and a chance to help us improve…
The latest evidence and resources for nurses and clinical support staff, and a chance to help us improve these blogs. The post…
POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes …
What’s new in the Critical Care literature – monthly updates
What’s new in the Critical Care literature – monthly updates
This blog highlights Cochrane evidence on treatments that have been investigated for people in hospital with moderate-to-severe…
Anticoagulants for people hospitalised with COVID‐19 – Cochrane…